DPH5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.484200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.877840E-01
Normal-vs-Stage2
2.596000E-02
Normal-vs-Stage3
9.304000E-02
Normal-vs-Stage4
5.826400E-01
Stage1-vs-Stage2
1.372430E-01
Stage1-vs-Stage3
6.862000E-02
Stage1-vs-Stage4
2.743600E-01
Stage2-vs-Stage3
2.609800E-01
Stage2-vs-Stage4
8.980200E-04
Stage3-vs-Stage4
1.081610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.998100E-02
Normal-vs-AfricanAmerican
1.634960E-01
Normal-vs-Asian
2.161400E-03
Caucasian-vs-AfricanAmerican
6.860000E-01
Caucasian-vs-Asian
1.055890E-02
AfricanAmerican-vs-Asian
4.127500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.918000E-02
Normal-vs-Female
5.666000E-02
Male-vs-Female
2.652000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.320000E-01
Normal-vs-Age(41-60Yrs)
8.863600E-02
Normal-vs-Age(61-80Yrs)
4.287500E-02
Normal-vs-Age(81-100Yrs)
1.461570E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.660800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.508200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.819800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.766500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.989200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.288200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.853600E-02
Normal-vs-Daily Drinker
1.107630E-02
Normal-vs-Weekly Drinker
3.899800E-02
Normal-vs-Occasional Drinker
1.270220E-01
Normal-vs-Social Drinker
1.683390E-01
Non Drinker-vs-Daily Drinker
6.466600E-01
Non Drinker-vs-Weekly Drinker
5.218800E-01
Non Drinker-vs-Occasional Drinker
3.145200E-01
Non Drinker-vs-Social Drinker
9.336200E-02
Daily Drinker-vs-Weekly Drinker
7.782800E-01
Daily Drinker-vs-Occasional Drinker
1.665440E-01
Daily Drinker-vs-Social Drinker
3.634100E-02
Weekly Drinker-vs-Occasional Drinker
1.867220E-01
Weekly Drinker-vs-Social Drinker
6.098300E-02
Occasional Drinker-vs-Social Drinker
5.472000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.911000E-01
Normal-vs-Grade 2
9.777000E-01
Normal-vs-Grade 3
9.171400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.026000E-01
Grade 1-vs-Grade 3
1.876180E-01
Grade 1-vs-Grade 4
9.911000E-01
Grade 2-vs-Grade 3
1.805160E-01
Grade 2-vs-Grade 4
9.777000E-01
Grade 3-vs-Grade 4
9.171400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.540100E-02
Normal-vs-NonDiabetic
3.030400E-02
Diabetic-vs-NonDiabetic
7.794800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.053500E-02
Normal-vs-NoPancreatitis
4.882500E-02
Pancreatitis-vs-NoPancreatitis
9.181600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.753780E-01
Normal-vs-N1
2.537900E-02
N0-vs-N1
2.063600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.948000E-02
Normal-vs-TP53-NonMutant
3.220800E-01
TP53-Mutant-vs-TP53-NonMutant
1.995890E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
